NCT04014933

Brief Summary

In addition to intraocular pressure blood perfusion pressure in the optic nerve is an important factor determing the cause of glaucoma. Increasing evidence suggests that in glaucoma patients retinal blood may be decreased.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2019

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

July 3, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 10, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 9, 2021

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

June 5, 2023

Status Verified

June 1, 2023

Enrollment Period

1.6 years

First QC Date

July 3, 2019

Last Update Submit

June 1, 2023

Conditions

Keywords

glaucomaretinal blood flowocular perfusion pressure

Outcome Measures

Primary Outcomes (2)

  • Coefficients of variation (COV)

    COVs from 3 measurements of ocular blood flow at visit 1 of observer 1 and at visit 1 of observer 1 and from observer 2 will be computed.

    1 month

  • intraclass correlation coefficients (ICCs)

    Intraobserver ICC, interobserver ICC, and inter-session ICC will be computed

    1 month

Secondary Outcomes (4)

  • Cofounder

    1 month

  • Cofounder

    1 month

  • Cofounder

    1 month

  • Cofounder

    1 month

Study Arms (3)

open-angle glaucoma

patients with a diagnosis of open-angle glaucoma, i.e. untreated IOP \>21mmHg plus glaucomatous disc changes and/or visual field defects typical for glaucoma

Diagnostic Test: LASER SPECKLE FLOWGRAPHY

normal tension glaucoma

patients with a diagnosis of normal tension glaucoma, i.e. untreated IOP \</=21mmHg plus glaucomatous disc changes and/or visual field defects typical for glaucoma

Diagnostic Test: LASER SPECKLE FLOWGRAPHY

healthy controls

individuals with normal optic disc and IOP \</21mmHg and normal visual fields

Diagnostic Test: LASER SPECKLE FLOWGRAPHY

Interventions

Non-invasive, real-time imaging and measurement of ocular blood flow of the optic disc and peripapillary region

healthy controlsnormal tension glaucomaopen-angle glaucoma

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

3 groups as described above will be recruted from the outpatient department of the Ophthalmology Department at the UniversityHospital Zurich, Zurich, Switzerland and the Ophthalmology Department at the Cantonal Hospital Aarau, Aarau, Switzerland

You may qualify if:

  • signed Patient Informed Consent form
  • Be at least 18 years old
  • Diagnosis of primary or secondary open-angle glaucoma or normal tension glaucoma or healthy controls

You may not qualify if:

  • Age \< 18 years
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant.
  • No vulnerable participants will be included in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Ophthalmology

Zurich, Canton of Zurich, 8091, Switzerland

Location

MeSH Terms

Conditions

Glaucoma, Open-AngleLow Tension GlaucomaGlaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye DiseasesOptic Nerve Diseases

Study Officials

  • Marc Töteberg-Harms, MD, FEBO

    UniversityHospital Zurich, Department of Ophthalmology, Zurich, Switzerland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 3, 2019

First Posted

July 10, 2019

Study Start

July 1, 2019

Primary Completion

February 9, 2021

Study Completion

December 31, 2021

Last Updated

June 5, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations